Redox remodeling: A candidate regulator of HMGB1 function in injured skeletal muscle

Annals of the New York Academy of Sciences

Volumn 1209, Issue 1, 2010, Pages 83-90

  Vezzoli, Michela ^a   Castellani, Patrizia ^b   Campana, Lara ^a   Corna, Gianfranca ^a   Bosurgi, Lidia ^c   Manfredi, Angelo A ^c   Bianchi, Marco E ^c   Rubartelli, Anna ^b   Rovere Querini, Patrizia ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Cell death; Cell therapy; HMGB1; Macrophages; Redox; Skeletal muscle

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; PRIMER DNA; REACTIVE OXYGEN METABOLITE;

ARTICLE; BIOLOGICAL ACTIVITY; CELL INFILTRATION; CELL PROLIFERATION; HUMAN; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MUSCLE INJURY; MUSCLE NECROSIS; NONHUMAN; OXIDATION REDUCTION STATE; STEM CELL; ANIMAL; CYTOLOGY; INJURY; MACROPHAGE; METABOLISM; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; HMGB1 PROTEIN; HUMANS; MACROPHAGES; MUSCLE, SKELETAL; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; STEM CELLS;

EID: 78049488758     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05748.x     Document Type: Article

References (54)

1. Chazaud, B. et al 2003. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J. Cell Biol. 163: 1133-1143.
2. Tidball, J.G. & M. Wehling-Henricks 2007. Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo. J. Physiol. 578: 327-336.
3. Brunelli, S. & P. Rovere-Querini 2008. The immune system and the repair of skeletal muscle. Pharmacol. Res. 58: 117-121.
4. Chazaud, B. et al 2009. Dual and beneficial roles of macrophages during skeletal muscle regeneration. Exerc. Sport Sci. Rev. 37: 18-22.
5. Tidball, J.G. & S.A. Villalta 2010. Regulatory interactions between muscle and the immune system during muscle regeneration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298: R1173-R1187.
6. Summan, M. et al 2006. Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290: R1488-R1495.
7. Shireman, P.K. et al 2007. MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration. J. Leukoc. Biol. 81: 775-785.
8. Arnold, L. et al 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204: 1057-1069.
9. Musaro, A. et al 2001. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 27: 195-200.
10. Pelosi, L. et al 2007. Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB J. 21: 1393-1402.
11. Geissmann, F. et al 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
12. Mantovani, A. & A. Sica 2010. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22: 231-237.
13. Gordon, S. & P.R. Taylor 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964.
14. Mantovani, A., A. Sica & M. Locati 2007. New vistas on macrophage differentiation and activation. Eur. J. Immunol. 37: 14-16.
15. Bacci, M. et al 2009. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularisation of lesions in a mouse model of disease. Am. J. Pathol. 175: 547-566.
16. Capobianco, A. et al 2010. Innate immune cells: gatekeepers of endometriotic lesions growth and vascularization. J. Endometriosis 2: 55-62.
17. Villalta, S.A. et al 2009. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum. Mol. Genet. 18: 482-496.
18. Ciciliot, S. & S. Schiaffino 2010. Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications. Curr. Pharm. Des. 16: 906-914.
19. Chlosta, S. et al 2006. The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect. Immun. 74: 3065-3067.
20. Nairz, M. et al 2007. The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol. 9: 2126-2140.
21. Paradkar, P.N. et al 2008. Iron depletion limits intracellular bacterial growth in macrophages. Blood 112: 866-874.
22. Recalcati, S. et al 2010. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur. J. Immunol. 40: 824-835.
23. Corna, G. et al 2010. Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica. In press.
24. Wallace, G.Q. & E.M. McNally 2009. Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. Annu. Rev. Physiol. 71: 37-57.
25. Lolmede, K. et al 2009. Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J. Leukoc. Biol. 85: 779-787.
26. Sampaolesi, M. et al 2003. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301: 487-492.
27. Sampaolesi, M. et al 2006. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444: 574-579.
28. Morosetti, R. et al 2007. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies. Stem Cells 25: 3173-3182.
29. Tedesco, F.S. et al 2010. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J. Clin. Invest. 120: 11-19.
30. Dellavalle, A. et al 2007. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat. Cell Biol. 9: 255-267.
31. Wang, H. et al 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251.
32. Oppenheim, J.J. & D. Yang 2005. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17: 359-365.
33. Zedler, S. & E. Faist 2006. The impact of endogenous triggers on trauma-associated inflammation. Curr. Opin. Crit. Care 12: 595-601.
34. Lotze, M.T. et al 2007. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol. Rev. 220: 60-81.
35. Rubartelli, A. & M.T. Lotze 2007. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 28: 429-436.
36. Bianchi, M.E. 2007. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81: 1-5.
37. Chavakis, E. et al 2007. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ. Res. 100: 204-212.
38. Palumbo, R. et al 2007. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation. J. Cell Biol. 179: 33-40.
39. Palumbo, R. et al 2009. Src family kinases are necessary for cell migration induced by extracellular HMGB1. J. Leukoc. Biol. 86: 617-623.
40. Germani, A., F. Limana & M.C. Capogrossi 2007. Pivotal advances: high-mobility group box 1 protein-a cytokine with a role in cardiac repair. J. Leukoc. Biol. 81: 41-45.
41. Kitahara, T. et al 2008. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc. Res. 80: 40-46.
42. Straino, S. et al 2008. High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J. Invest. Dermatol. 128: 1545-1553.
43. Kohno, T. et al 2009. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc. Res. 81: 565-573.
44. Biscetti, F. et al 2010. High-mobility group box 1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes. 59: 1496-1505.
45. De Mori, R. et al 2007. Multiple effects of high mobility group box protein 1 in skeletal muscle regeneration. Arterioscler. Thromb. Vasc. Biol. 27: 2377-2383.
46. Grundtman, C. et al 2010. Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J. 24: 570-578.
47. Sims, G.P. et al 2010. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 28: 367-388.
48. Rubartelli, A. & R. Sitia 2009. Stress as an intercellular signal: the emergence of stress-associated molecular patterns (SAMP). Antioxid. Redox Signal 11: 2621-2629.
49. Carta, S. et al 2009. DAMPs and inflammatory processes: the role of redox in the different outcomes. J. Leukoc. Biol. 86: 549-555.
50. Hoppe, G. et al 2006. Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp. Cell Res. 312: 3526-3538.
51. Yang, H. et al 2010.A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl. Acad. Sci. USA 107: 11942-11947.
52. Sarsour, E.H. et al 2009. Redox control of the cell cycle in health and disease. Antioxid. Redox Signal 11: 2985-3011.
53. Rando, T.A. 2002. Oxidative stress and the pathogenesis of muscular dystrophies. Am. J. Phys. Med. Rehabil. 81: S175-S186.
54. Lim, S.Y. et al 2009. Oxidative modifications of S100 proteins: functional regulation by redox. J. Leukoc. Biol. 86: 577-587.